Director W. Thorpe McKenzie retires; XBiotech to maintain one-member audit and compensation committees

XBiotech Inc.

W. Thorpe McKenzie retired from the Board effective March 27, 2025.
Company notified NASDAQ on April 1, 2025, of the retirement and intent to fill vacancies.
Audit Committee and Compensation Committee will each operate with one member under NASDAQ exceptions.
Vacancies to be filled within the time prescribed by NASDAQ Rules 5605(c)(4) and 5605(d)(4).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.